Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole

Susan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash · 2024

Read Investigation of a fully mechanistic physiologically based pharmacokinetics model of absorption to support predictions of milk concentrations in breastfeeding women and the exposure of infants: A case study for albendazole by Susan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11578140.txt.

Description

Computer models estimate how much deworming drug reaches breast milk, Susan Cole and co-authors report in a 2024 study. Guidance now tells mothers to stop nursing on albendazole for lack of data. A body-simulation model predicts drug and active breakdown levels in blood and milk.

The model nails adult exposure and the food effect but misses some child data. Milk-to-blood ratios ran too high for the fatty parent drug, less so for its leaner metabolite. Worst-case math still puts infant doses low. More real milk samples are needed before guidance can safely soften, the authors caution.

Catalog record

CREATORSusan Cole, Maria Malamatari, Andrew Butler, Mahnoor Arshad, Essam Kerwash
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11578140

Browse the full library · About the Tower of Babel